Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 186

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Hereditary C2 Deficiency in Sweden: Frequent Occurrence of Invasive Infection, Atherosclerosis, and Rheumatic Disease

Jönsson, Göran, Truedsson, Lennart, Sturfelt, Gunnar, Oxelius, Vivi-Anne, Braconier, Jean Henrik, Sjöholm, Anders G. · 2005 · Medicine

Abstract

Although frequently asymptomatic, homozygous C2 deficiency (C2D) is known to be associated with severe infections and rheumatic disease. We describe the clinical findings in 40 persons with C2D from 33 families identified in Sweden over 25 years. Medical records covering 96% of the accumulated person-years were reviewed, giving a mean observation time of 39 years (range, 1-77 yr). Severe infection was the predominant clinical manifestation in the cohort: 23 patients had a past history of invasive infections, mainly septicemia or meningitis caused by Streptococcus pneumoniae, and 12 patients had repeated infections of this kind. Nineteen patients had at least 1 episode of pneumonia, and recurrent pneumonia was documented in 10 patients. Repeated infections occurred mainly during infancy and childhood. Systemic lupus erythematosus was found in 10 patients. Another 7 patients had undifferentiated connective tissue disease (n = 4) or vasculitis (n = 3). We found no correlation between susceptibility to invasive infection and rheumatologic disease. Cardiovascular disease occurred at a high rate, with a total of 10 acute myocardial infarctions and 5 cerebrovascular episodes in 6 patients. Causes of death among the C2D patients were infection (n = 5), acute myocardial infarction (n = 3), and cancer (n = 1). We suggest that severe infection may be the principal clinical manifestation of C2D. We also provide novel evidence for a possible role of C2D in the development of atherosclerosis consistent with findings in mannan-binding deficiency and experimental C3 deficiency. In addition, we confirm the well-known association between C2D and systemic lupus erythematosus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.md.0000152371.22747.1e

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 65

  1. Agnello, 1986, Lupus diseases associated with hereditary and acquired deficiencies of complement., Springer Semin Immunopathol, 9, 161, 10.1007/BF02099020 · doi:10.1007/bf02099020
  2. Albani, 1996, A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis., Immunol Today, 17, 466, 10.1016/0167-5699(96)20029-G · doi:10.1016/0167-5699(96)20029-g
  3. Alper, 1984, Inherited deficiencies of complement proteins in man., Springer Semin Immunopathol, 7, 251, 10.1007/BF01893022 · doi:10.1007/bf01893022
  4. Alper, 2003, Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency., J Clin Immunol, 23, 297, 10.1023/A:1024540917593 · DOI
  5. Back, 1999, Towards common reference intervals in clinical chemistry. An attempt at harmonization between three hospital laboratories in Skane, Sweden., Clin Chem Lab Med, 37, 573, 10.1515/CCLM.1999.091 · DOI
  6. Best, 2004, Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study., Circulation, 109, 471, 10.1161/01.CIR.0000109757.95461.10 · DOI
  7. Bhakdi, 1998, Complement and atherogenesis: the unknown connection., Ann Med, 30, 503, 10.3109/07853899809002596 · DOI
  8. Bird, 1988, The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation., Eur J Immunol, 18, 1217, 10.1002/eji.1830180811 · doi:10.1002/eji.1830180811
  9. Bodmer, 1997, Nomenclature for factors of the HLA system, 1996., Vox Sang, 73, 105, 10.1159/000461915 · doi:10.1159/000461915
  10. Boersma, 2003, Acute myocardial infarction., Lancet, 361, 847, 10.1016/S0140-6736(03)12712-2 · DOI · Paper page
  11. Brown, 1983, The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream., Rev Infect Dis, 5, S797, 10.1093/clinids/5.Supplement_4.S797 · DOI
  12. Brown, 2002, The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice., Proc Natl Acad Sci U S A, 99, 16969, 10.1073/pnas.012669199 · DOI · Paper page
  13. Buono, 2002, Influence of C3 deficiency on atherosclerosis., Circulation, 105, 3025, 10.1161/01.CIR.0000019584.04929.83 · DOI · Paper page
  14. Canto, 2003, Major risk factors for cardiovascular disease: debunking the "only 50%" myth., JAMA, 290, 947, 10.1001/jama.290.7.947 · DOI
  15. Cooper, 1988, Laboratory investigations of complement proteins and complement receptors., Baillieres Clin Immunol Allergy, 2, 263
  16. D'Agostino, 2000, Primary and subsequent coronary risk appraisal: new results from the Framingham study., Am Heart J, 139, 272, 10.1016/S0002-8703(00)90236-9 · DOI · Paper page
  17. DeWitt, 1999, Group B streptococcal disease in a child beyond early infancy with a deficiency of the second component of complement (C2)., Pediatr Infect Dis J, 18, 77, 10.1097/00006454-199901000-00024 · doi:10.1097/00006454-199901000-00024
  18. Edwards, 1985, The role of complement in opsonization of GBS., Antibiot Chemother, 35, 170, 10.1159/000410371 · doi:10.1159/000410371
  19. Fasano, 1990, Recurrent systemic bacterial infections in homozygous C2 deficiency., Pediatr Allergy Immunol, 1, 46, 10.1111/j.1399-3038.1990.tb00008.x · doi:10.1111/j.1399-3038.1990.tb00008.x
  20. Figueroa, 1991, Infectious diseases associated with complement deficiencies., Clin Microbiol Rev, 4, 359, 10.1128/CMR.4.3.359 · DOI · Paper page
  21. Fijen, 2000, The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals., Clin Exp Immunol, 120, 338, 10.1046/j.1365-2249.2000.01208.x · DOI
  22. Fries, 1984, C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I., J Exp Med, 160, 1640, 10.1084/jem.160.6.1640 · DOI
  23. Geertinger, 1975, On the arterogenic effect of cholesterol feeding in rabbits with congenital complement (C6) deficiency., Artery, 1, 177
  24. Genin, 1978, Familial glomerulonephritis and hereditary deficiency of C2., Arch Fr Pediatr, 35, 1085
  25. Ginzler, 1978, Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus., Arthritis Rheum, 21, 37, 10.1002/art.1780210107 · DOI · Paper page
  26. Hazlewood, 1992, An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies., Clin Exp Immunol, 87, 404, 10.1111/j.1365-2249.1992.tb03010.x · doi:10.1111/j.1365-2249.1992.tb03010.x
  27. Hermaszewski, 1993, Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications., Q J Med, 86, 31
  28. Hibberd, 1999, Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group., Lancet, 353, 1049, 10.1016/S0140-6736(98)08350-0 · DOI · Paper page
  29. Hjermann, 1981, Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men., Lancet, 2, 1303, 10.1016/S0140-6736(81)91338-6 · DOI · Paper page
  30. Janoff, 1999, Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes., J Clin Invest, 104, 1139, 10.1172/JCI6310 · DOI
  31. Johnson, 1992, Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing., J Biol Chem, 267, 9347, 10.1016/S0021-9258(19)50430-6 · DOI
  32. Johnson, 1983, Complement components in 100 newborns and their mothers determined by electroimmunoassay., Acta Pathol Microbiol Immunol Scand C, 91, 147
  33. Knutzen Steuer, 1989, Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement., J Immunol, 143, 2256, 10.4049/jimmunol.143.7.2256 · doi:10.4049/jimmunol.143.7.2256
  34. Lucisano Valim, 1991, The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions., Clin Exp Immunol, 84, 1, 10.1111/j.1365-2249.1991.tb08115.x · DOI · Paper page
  35. Madsen, 1998, Association of mannose-binding-lectin deficiency with severe atherosclerosis., Lancet, 352, 959, 10.1016/S0140-6736(05)61513-9 · DOI · Paper page
  36. Matsushita, 1995, Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation., Immunobiology, 194, 443, 10.1016/S0171-2985(11)80110-5 · DOI
  37. Matsushita, 2002, The role of ficolins in innate immunity., Immunobiology, 205, 490, 10.1078/0171-2985-00149 · DOI
  38. Metz, 2003, Implications of cigarette smoking for the management of patients with acute coronary syndromes., Prog Cardiovasc Dis, 46, 1, 10.1016/S0033-0620(03)00075-6 · DOI
  39. Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells., Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 · DOI · Paper page
  40. Mitchell, 2002, C1q deficiency and autoimmunity: the effects of genetic background on disease expression., J Immunol, 168, 2538, 10.4049/jimmunol.168.5.2538 · DOI · Paper page
  41. Newman, 1978, Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway., N Engl J Med, 299, 290, 10.1056/NEJM197808102990606 · DOI
  42. Ochs, 1993, Regulation of antibody responses: the role of complement and adhesion molecules., Clin Immunol Immunopathol, 67, 33, 10.1006/clin.1993.1081 · DOI
  43. Ohlenschlaeger, 2004, Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus., N Engl J Med, 351, 260, 10.1056/NEJMoa033122 · DOI · Paper page
  44. Pickering, 2000, Systemic lupus erythematosus, complement deficiency, and apoptosis., Adv Immunol, 76, 227, 10.1016/S0065-2776(01)76021-X · DOI · Paper page
  45. Platonov, 1998, Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals., Clin Exp Immunol, 111, 97, 10.1046/j.1365-2249.1998.00484.x · DOI
  46. Ratnoff, 1983, The role of antibody in the activation of the alternative complement pathway., Springer Semin Immunopathol, 6, 361, 10.1007/BF02116280 · DOI
  47. Ross, 1984, Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency., Medicine (Baltimore), 63, 243, 10.1097/00005792-198409000-00001 · DOI · Paper page
  48. Rossi, 2001, Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2., J Biol Chem, 276, 40880, 10.1074/jbc.M105934200 · DOI · Paper page
  49. Roy, 2002, MBL genotype and risk of invasive pneumococcal disease: a case-control study., Lancet, 359, 1569, 10.1016/S0140-6736(02)08516-1 · DOI · Paper page
  50. Rugonfalvi-Kiss, 2002, Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin., Circulation, 106, 1071, 10.1161/01.CIR.0000027137.96791.6A · DOI
  51. Schwertz, 1991, Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families., Eur J Pediatr, 150, 647, 10.1007/BF02072626 · doi:10.1007/bf02072626
  52. Selander, 2000, Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG., J Clin Immunol, 20, 138, 10.1023/A:1006638631581 · DOI
  53. Selander, 1999, Low concentrations of immunoglobulin G antibodies to Salmonella serogroup C in C2 deficiency: suggestion of a mannan-binding lectin pathway-dependent mechanism., Scand J Immunol, 50, 555, 10.1046/j.1365-3083.1999.00665.x · DOI
  54. Seligmann, 1979, Hereditary C2 deficiency associated with common variable immunodeficiency., Ann Intern Med, 91, 216, 10.7326/0003-4819-91-2-216 · doi:10.7326/0003-4819-91-2-216
  55. Sjoholm, 1990, Inherited complement deficiency states: implications for immunity and immunological disease., Apmis, 98, 861, 10.1111/j.1699-0463.1990.tb05008.x · doi:10.1111/j.1699-0463.1990.tb05008.x
  56. Sjoholm, 1987, C2 deficiency, moderately low IgG2 concentrations and lack of the G2m(23) allotype marker in a child with repeated bacterial infections., Acta Paediatr Scand, 76, 533, 10.1111/j.1651-2227.1987.tb10514.x · doi:10.1111/j.1651-2227.1987.tb10514.x
  57. Skattum, 1997, Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies., J Intern Med, 242, 455, 10.1111/j.1365-2796.1997.tb00018.x · doi:10.1111/j.1365-2796.1997.tb00018.x
  58. Stengaard-Pedersen, 2003, Inherited deficiency of mannan-binding lectin-associated serine protease 2., N Engl J Med, 349, 554, 10.1056/NEJMoa022836 · DOI · Paper page
  59. Stiehm, 1966, Serum levels of immune globulins in health and disease: a survey., Pediatrics, 37, 715, 10.1542/peds.37.5.715 · DOI · Paper page
  60. Sturfelt, 2000, Novel roles of complement in systemic lupus erythematosus-hypothesis for a pathogenetic vicious circle., J Rheumatol, 27, 661
  61. Truedsson, 1993, Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B-region and absence of disease association due to linked class II genes., J Immunol, 151, 5856, 10.4049/jimmunol.151.10.5856 · DOI
  62. Truedsson, 1981, Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel., Acta Pathol Microbiol Scand C, 89, 161
  63. Turner, 2000, Mannose-binding lectin: structure, function, genetics and disease associations., Rev Immunogenet, 2, 305
  64. Walport, 2001, Complement. First of two parts., N Engl J Med, 344, 1058, 10.1056/NEJM200104053441406 · DOI · Paper page
  65. Zimmerli, 1991, Humoral immune response to pneumococcal antigen 23-F in an asplenic patient with recurrent fulminant pneumococcaemia., J Infect, 22, 59, 10.1016/0163-4453(91)91010-U · doi:10.1016/0163-4453(91)91010-u

Cited by

See all 186

Metadata

Authors
Jönsson, G., Truedsson, L., Sturfelt, G., Oxelius, V.-A., Braconier, J. H., & Sjöholm, A. G.
Venue
Medicine
Published
2005-01
Volume
84
Issue
1
Pages
23-34
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2054359284
Cited by
186
References
5
FWCI
4.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hereditary C2 Deficiency in Sweden: Frequent Occurrence of Invasive Infection, Atherosclerosis, and Rheumatic Disease. https://app.cochat.ai/papers/10.1097/01.md.0000152371.22747.1e
The paper
Jönsson, G., Truedsson, L., Sturfelt, G., Oxelius, V.-A., Braconier, J. H., & Sjöholm, A. G. (2005). Hereditary C2 Deficiency in Sweden: Frequent Occurrence of Invasive Infection, Atherosclerosis, and Rheumatic Disease. Medicine. https://doi.org/10.1097/01.md.0000152371.22747.1e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.